Related Experiment Videos
[Nitric oxide and inflammatory bowel disease]
M A García-González1, A S Peña
1Departamento de Gastroenterología, Vrije Universiteit, Amsterdam, Países Bajos.
Revista Espanola De Enfermedades Digestivas
|February 12, 1999
Summary
Nitric oxide (NO) plays a dual role in inflammatory bowel disease (IBD). While small amounts preserve gut integrity, excess NO from inducible nitric oxide synthase (iNOS) worsens inflammation and injury.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Context:
- Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, involves chronic intestinal inflammation.
- Enhanced production of nitric oxide (NO) and nitric oxide synthase (NOS) activity are observed in IBD patients.
Purpose:
- To review the pathways, mechanisms, functions, regulation, immunogenetics, and role of NO in IBD.
- To explore the potential of targeting NO pathways for novel IBD therapies.
Summary:
- Nitric oxide (NO) is a key biological mediator. Endothelial constitutive NOS (ecNOS) may protect the intestinal mucosa, while inducible NOS (iNOS) contributes to inflammation, injury, and immune response amplification in IBD.
- Understanding NO's physiopathology in IBD is crucial for developing targeted treatments.
Impact:
- Selective inhibitors of NOS isoforms could offer a new therapeutic strategy for managing IBD.
- Deeper knowledge of NO's role may lead to improved patient outcomes in inflammatory bowel disease.